Colleen Allen
Family · Newark, DENPI 1255738688
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Boehringer Ingelheim$798
- Merck$715
- Pfizer$542
- AstraZeneca$478
- Sanofi-aventis U.S. LLC$437
- plus $3K from 18 others
What the payments were for
- Food & beverage$6,668100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 85 | $1,202 |
| Boehringer Ingelheim | 44 | $798 |
| Merck | 41 | $715 |
| Pfizer | 34 | $542 |
| AstraZeneca | 25 | $478 |
| Sanofi-aventis U.S. LLC | 36 | $437 |
| Esperion Therapeutics, Inc. | 20 | $394 |
| Novo Nordisk | 20 | $364 |
| Bayer | 17 | $359 |
| Lexicon Pharmaceuticals, Inc. | 18 | $323 |
| Amgen | 14 | $263 |
| Johnson & Johnson | 11 | $164 |
| Kowa Pharmaceuticals America, Inc. | 9 | $117 |
| E.r. Squibb & Sons, L.L.C. | 5 | $98 |
| Lilly USA, LLC | 4 | $76 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $65 |
| Abbott | 3 | $63 |
| Amarin Pharma, Inc. | 4 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $57 |
| Agepha Pharma FZ LLC | 2 | $32 |
| Gilead | 1 | $26 |
| Heartflow, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,691 in reported general payments places this provider in the 90th percentile of 523 family providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 268 | $355,997 |
| XareltoRivaroxaban | 114 | $148,564 |
| EntrestoSacubitril/Valsartan | 84 | $136,298 |
| JardianceEmpagliflozin | 60 | $90,378 |
| MultaqDronedarone Hcl | 15 | $33,217 |
| OzempicSemaglutide | 21 | $23,343 |
| NexletolBempedoic Acid | 11 | $7,727 |
| Rosuvastatin Calcium | 250 | $7,488 |
| Flecainide Acetate | 119 | $7,458 |
| Carvedilol | 597 | $7,173 |
| Atorvastatin Calcium | 301 | $5,458 |
| Nebivolol Hcl | 56 | $4,719 |
| Niacin ErNiacin | 27 | $4,673 |
| Amiodarone Hcl | 181 | $4,393 |
| Ezetimibe | 72 | $3,408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $542 | $355,997268 claims |
| Johnson & JohnsonXarelto | $164 | $148,564114 claims |
| NovartisEntresto | $1,202 | $136,29884 claims |
| Boehringer IngelheimJardiance | $798 | $90,37860 claims |
| Sanofi-aventis U.S. LLCMultaq | $437 | $33,21715 claims |
| Novo NordiskOzempic | $364 | $23,34321 claims |
| Esperion Therapeutics, Inc.Nexletol | $394 | $7,72711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 523 family providers in Delaware.
Other family in Newark
- Kathy GallagherNewark$53K
- Jodie DelesioNewark$50K
- Melanie HiesterNewark$9K
- Samatha GrayNewark$9K
- Byron MayNewark$8K
- Clare MatisNewark$8K
- Christine MazzolaNewark$7K
- Kelsey FrybergerNewark$7K
- Mallory KowalskiNewark$7K
- Palak DesaiNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.